Latest Varian Medical Systems (VAR) Headlines A
Post# of 39
Posted On: 03/14/2014 9:55:51 AM
Latest Varian Medical Systems (VAR) Headlines
Appointments, Stock Price Updates, Acquisitions, Financial Results and Technology Deployments - Analyst Notes on Stryker, ArthroCare, Novavax, Cooper, and Varian
PR Newswire - 1 hr 55 mins ago
Today, Analysts Review released its analysts' notes regarding Stryker Corporation (NYSE: SYK), ArthroCare Corporation (NASDAQ: ARTC), Novavax, Inc. (NASDAQ: NVAX), The Cooper Companies, Inc. (NYSE: COO), and Varian Medical Systems, Inc. (NYSE: VAR). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Final Glance: Health Care Equipment companies
AP - Thu Mar 13, 5:05PM CDT
NEW YORK (AP) — Shares of some top health care equipment companies were down at the close of trading:
Cancer Center Uses Varian Medical's Radiosurgery System - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 1:50PM CDT
VAR's Calypso "GPS for the Body" enables targeting precision for tracing tumor position in real time.
Midday Glance: Health Care Equipment companies
AP - Thu Mar 13, 12:59PM CDT
NEW YORK (AP) — Shares of some top health care equipment companies are down at 1 p.m.:
Early Glance: Health Care Equipment companies
AP - Thu Mar 13, 9:16AM CDT
NEW YORK (AP) — Shares of some top health care equipment companies are mixed at 10 a.m.:
External Beam Radiation Therapy Devices Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2017
M2 - Thu Mar 13, 4:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bzh75q/external_beam) has announced the addition of the "External Beam Radiation Therapy Devices Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2017" report to their offering. The global external beam radiation therapy devices market was worth $3,308.6 million in 2012 and is expected to reach $4,304.9 million in 2017, growing at a CAGR of 5.4% from 2013 to 2017. External beam radiotherapy market is primarily driven by electron emitting high energy linear accelerators, followed by compact advanced radiotherapy systems and proton therapy systems. In comprehensive compact advanced radiotherapy market, Gamma Knife holds the major share presently compared to CyberKnife and TomoTherapy devices. As accuracy is the main concern for the intracranial treatment to protect sensitive neighbouring tissues, Gamma Knife was always the first choice of the physician for its huge popularity. Proton machine market is highly dominated by huge cyclotron machines. The rest of the market is occupied by synchrotron machines. Comprehensiveness of entire cyclotron system is the major driver for this market. A LINAC or linear accelerator is the most important component of external beam therapy devices and perpetual variations and development in their characteristics such as electron-emitting high energy machines and proton therapy machines have rendered scope for the evolution of different types of external beam therapy. Further miniaturization of devices has led to introduction of radiosurgery systems such as Gamma Knife, TomoTherapy and CyberKnife. Radiosurgery systems though being a small contributor, they are the most technologically advanced area in the external beam therapy systems market. Synchrotron and cyclotron systems have a wide range of applications and high contribution to the field of radiation oncology. External beam radiation therapy forms the major part of all radiotherapy procedures, being given principal importance over the other two technologies namely internal beam radiation or brachytherapy and systemic radiation therapy. Continuous technical upheaval combined with efficient reimbursement support from developed countries of North America and Europe are the major reasons for this huge external beam radiation therapy market growth. In terms of technology, IMRT procedure has become a standard for treatment in prostate cancer, CNS and head and neck cancer due to its multiple targets, multiple critical avoidance and differential weightages to critical tissues. The considerable penetration of IGRT and other advanced technologies that significantly answer the growing demand of obtaining real time pictures during treatment procedures for better outcomes has marred the market growth of IMRT. However, healthy reimbursement policies and governmental support will continue to drive this market significantly in the coming years. Rapid introduction of new therapeutic technologies of radiotherapy have made this market dynamic in nature. Key Topics Covered - Introduction to the Report - Market Synopsis - Market Dynamics - Products Market Size & Forecast - Global External Beam Radiation Therapy Devices - Applications Market Size & Forecast - Global External Beam Radiation Therapy Devices - Technology Market Size & Forecast - Global External Beam Radiation Therapy Devices - Geography Market Size & Forecast - Global External Beam Radiation Therapy Devices - Key Players Analysis: External Beam Radiation Therapy Devices Market, 2012 (%) - Company Profiles Companies Mentioned - Accuray - Covidien - Elekta - iCAD - Ion Beam Applications - ProTom International - Siemens Healthcare - Varian Medical Systems For more information visit http://www.researchandmarkets.com/research/bz...ernal_beam About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Varian Medical Systems Signs Agreement to Acquire Velocity Software Platform for Data-Driven Clinical Decision Making in Cancer Centers
PR Newswire - Wed Mar 12, 7:00AM CDT
Varian Medical Systems, Inc., (NYSE: VAR) today announced it has signed an agreement with Velocity Medical Solutions, LLC to acquire certain assets of Velocity, a privately-held Atlanta-based developer of specialized software for cancer clinics.
Internal Beam & Systemic Radiation Therapy Devices Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2017
M2 - Wed Mar 12, 3:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/t7wqw3/internal_beam_and) has announced the addition of the "Internal Beam & Systemic Radiation Therapy Devices Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2017" report to their offering. Rising cancer cases have made radiotherapy a standard procedure for oncology treatment. With a prominent rise in their GDP, emerging nations act as the future growth opportunities for the global radiotherapy market. Internal radiation therapy or brachytherapy is one of the oldest techniques for the treatment of cancerous tumors. As per the procedures, this process is categorized into permanent and temporary procedures where low dose rate and high dose rate brachytherapy are applied respectively. This report comprises of a holistic analysis of the market in terms of forces affecting the market. Its sub-components/forces include bargaining power of suppliers, bargaining power of buyers, threat of substitutes, threat of new entrants and competitive rivalry. The study analyzes the market for segments such as brachytherapy seeds, applicators and afterloaders and electronic brachytherapy along with their applications that include Prostate cancer, gynecological cancer, breast cancer, cervical cancer, penile cancer, lung cancer, head and neck cancer and esophageal cancer. The study also analyzes four regions namely, North America, Europe, Asia-Pacific and Rest of the World for the Internal Beam Radiation Devices Market. The report elucidates several dynamics of the market such as the drivers, inhibitors, and opportunities that are illustrated throughout the report. It provides current and future outlook for the market on a global level as well as a focused view on independent sub-segments within the market. The report also profiles key market players Accuray Inc., Angiodynamics Inc., Boston Scientific Corporation, C.R. Bard, Cardinal Health Inc., Covidien PLC, GE Healthcare, Siemens Healthcare, Theragenics Corporation and others. The study provides a market share analysis for the year 2012 with respect to key players and also provides recent developments for all profiled companies. Key Topics Covered - Introduction to the Report - Market Synopsis - Market Dynamics - Products Market Size & Forecast - Global Internal Beam Radiation Therapy Devices - Products Market Size & Forecast - Global Systemic Radiation Therapy Devices - Applications Market Size & Forecast - Global Internal Beam Radiation and Systemic Therapy Devices - Technology Market Size & Forecast - Global Internal Beam Radiation Therapy Devices - Geography Market Size & Forecast - Global Internal Beam & Systemic Radiation Therapy Devices - Competitive Scenario: Key Players - Company Profiles Companies Mentioned - Boston Scientific - C.R. Bard - Eckert & Ziegler BEBIG - Elekta AB - GE Healthcare - IBA - Nordion - Theragenics - Varian Medical Systems For more information visit http://www.researchandmarkets.com/research/t7...l_beam_and About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Varian Medical Systems Hit 52-Week High - Analyst Blog
Souvik Guha - Zacks Investment Research - Tue Mar 11, 12:38PM CDT
Shares of VAR started escalating following its announcement of several events supporting the increased adoption of the company's technology and the exhibition of a comprehensive line of products in the pipeline.
Meridian to Become First Health Network in New Jersey to Plan Systemwide Deployment of TrueBeam(TM) Technology for Advanced Radiotherapy Treatments
PR Newswire - Tue Mar 11, 7:00AM CDT
Meridian Health of New Jersey is initiating a program to deploy TrueBeam(TM) technology from Varian Medical Systems (NYSE:VAR) across its network of cancer treatment clinics.
Appointments, Stock Price Updates, Acquisitions, Financial Results and Technology Deployments - Analyst Notes on Stryker, ArthroCare, Novavax, Cooper, and Varian
PR Newswire - 1 hr 55 mins ago
Today, Analysts Review released its analysts' notes regarding Stryker Corporation (NYSE: SYK), ArthroCare Corporation (NASDAQ: ARTC), Novavax, Inc. (NASDAQ: NVAX), The Cooper Companies, Inc. (NYSE: COO), and Varian Medical Systems, Inc. (NYSE: VAR). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Final Glance: Health Care Equipment companies
AP - Thu Mar 13, 5:05PM CDT
NEW YORK (AP) — Shares of some top health care equipment companies were down at the close of trading:
Cancer Center Uses Varian Medical's Radiosurgery System - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 1:50PM CDT
VAR's Calypso "GPS for the Body" enables targeting precision for tracing tumor position in real time.
Midday Glance: Health Care Equipment companies
AP - Thu Mar 13, 12:59PM CDT
NEW YORK (AP) — Shares of some top health care equipment companies are down at 1 p.m.:
Early Glance: Health Care Equipment companies
AP - Thu Mar 13, 9:16AM CDT
NEW YORK (AP) — Shares of some top health care equipment companies are mixed at 10 a.m.:
External Beam Radiation Therapy Devices Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2017
M2 - Thu Mar 13, 4:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bzh75q/external_beam) has announced the addition of the "External Beam Radiation Therapy Devices Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2017" report to their offering. The global external beam radiation therapy devices market was worth $3,308.6 million in 2012 and is expected to reach $4,304.9 million in 2017, growing at a CAGR of 5.4% from 2013 to 2017. External beam radiotherapy market is primarily driven by electron emitting high energy linear accelerators, followed by compact advanced radiotherapy systems and proton therapy systems. In comprehensive compact advanced radiotherapy market, Gamma Knife holds the major share presently compared to CyberKnife and TomoTherapy devices. As accuracy is the main concern for the intracranial treatment to protect sensitive neighbouring tissues, Gamma Knife was always the first choice of the physician for its huge popularity. Proton machine market is highly dominated by huge cyclotron machines. The rest of the market is occupied by synchrotron machines. Comprehensiveness of entire cyclotron system is the major driver for this market. A LINAC or linear accelerator is the most important component of external beam therapy devices and perpetual variations and development in their characteristics such as electron-emitting high energy machines and proton therapy machines have rendered scope for the evolution of different types of external beam therapy. Further miniaturization of devices has led to introduction of radiosurgery systems such as Gamma Knife, TomoTherapy and CyberKnife. Radiosurgery systems though being a small contributor, they are the most technologically advanced area in the external beam therapy systems market. Synchrotron and cyclotron systems have a wide range of applications and high contribution to the field of radiation oncology. External beam radiation therapy forms the major part of all radiotherapy procedures, being given principal importance over the other two technologies namely internal beam radiation or brachytherapy and systemic radiation therapy. Continuous technical upheaval combined with efficient reimbursement support from developed countries of North America and Europe are the major reasons for this huge external beam radiation therapy market growth. In terms of technology, IMRT procedure has become a standard for treatment in prostate cancer, CNS and head and neck cancer due to its multiple targets, multiple critical avoidance and differential weightages to critical tissues. The considerable penetration of IGRT and other advanced technologies that significantly answer the growing demand of obtaining real time pictures during treatment procedures for better outcomes has marred the market growth of IMRT. However, healthy reimbursement policies and governmental support will continue to drive this market significantly in the coming years. Rapid introduction of new therapeutic technologies of radiotherapy have made this market dynamic in nature. Key Topics Covered - Introduction to the Report - Market Synopsis - Market Dynamics - Products Market Size & Forecast - Global External Beam Radiation Therapy Devices - Applications Market Size & Forecast - Global External Beam Radiation Therapy Devices - Technology Market Size & Forecast - Global External Beam Radiation Therapy Devices - Geography Market Size & Forecast - Global External Beam Radiation Therapy Devices - Key Players Analysis: External Beam Radiation Therapy Devices Market, 2012 (%) - Company Profiles Companies Mentioned - Accuray - Covidien - Elekta - iCAD - Ion Beam Applications - ProTom International - Siemens Healthcare - Varian Medical Systems For more information visit http://www.researchandmarkets.com/research/bz...ernal_beam About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Varian Medical Systems Signs Agreement to Acquire Velocity Software Platform for Data-Driven Clinical Decision Making in Cancer Centers
PR Newswire - Wed Mar 12, 7:00AM CDT
Varian Medical Systems, Inc., (NYSE: VAR) today announced it has signed an agreement with Velocity Medical Solutions, LLC to acquire certain assets of Velocity, a privately-held Atlanta-based developer of specialized software for cancer clinics.
Internal Beam & Systemic Radiation Therapy Devices Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2017
M2 - Wed Mar 12, 3:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/t7wqw3/internal_beam_and) has announced the addition of the "Internal Beam & Systemic Radiation Therapy Devices Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2017" report to their offering. Rising cancer cases have made radiotherapy a standard procedure for oncology treatment. With a prominent rise in their GDP, emerging nations act as the future growth opportunities for the global radiotherapy market. Internal radiation therapy or brachytherapy is one of the oldest techniques for the treatment of cancerous tumors. As per the procedures, this process is categorized into permanent and temporary procedures where low dose rate and high dose rate brachytherapy are applied respectively. This report comprises of a holistic analysis of the market in terms of forces affecting the market. Its sub-components/forces include bargaining power of suppliers, bargaining power of buyers, threat of substitutes, threat of new entrants and competitive rivalry. The study analyzes the market for segments such as brachytherapy seeds, applicators and afterloaders and electronic brachytherapy along with their applications that include Prostate cancer, gynecological cancer, breast cancer, cervical cancer, penile cancer, lung cancer, head and neck cancer and esophageal cancer. The study also analyzes four regions namely, North America, Europe, Asia-Pacific and Rest of the World for the Internal Beam Radiation Devices Market. The report elucidates several dynamics of the market such as the drivers, inhibitors, and opportunities that are illustrated throughout the report. It provides current and future outlook for the market on a global level as well as a focused view on independent sub-segments within the market. The report also profiles key market players Accuray Inc., Angiodynamics Inc., Boston Scientific Corporation, C.R. Bard, Cardinal Health Inc., Covidien PLC, GE Healthcare, Siemens Healthcare, Theragenics Corporation and others. The study provides a market share analysis for the year 2012 with respect to key players and also provides recent developments for all profiled companies. Key Topics Covered - Introduction to the Report - Market Synopsis - Market Dynamics - Products Market Size & Forecast - Global Internal Beam Radiation Therapy Devices - Products Market Size & Forecast - Global Systemic Radiation Therapy Devices - Applications Market Size & Forecast - Global Internal Beam Radiation and Systemic Therapy Devices - Technology Market Size & Forecast - Global Internal Beam Radiation Therapy Devices - Geography Market Size & Forecast - Global Internal Beam & Systemic Radiation Therapy Devices - Competitive Scenario: Key Players - Company Profiles Companies Mentioned - Boston Scientific - C.R. Bard - Eckert & Ziegler BEBIG - Elekta AB - GE Healthcare - IBA - Nordion - Theragenics - Varian Medical Systems For more information visit http://www.researchandmarkets.com/research/t7...l_beam_and About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Varian Medical Systems Hit 52-Week High - Analyst Blog
Souvik Guha - Zacks Investment Research - Tue Mar 11, 12:38PM CDT
Shares of VAR started escalating following its announcement of several events supporting the increased adoption of the company's technology and the exhibition of a comprehensive line of products in the pipeline.
Meridian to Become First Health Network in New Jersey to Plan Systemwide Deployment of TrueBeam(TM) Technology for Advanced Radiotherapy Treatments
PR Newswire - Tue Mar 11, 7:00AM CDT
Meridian Health of New Jersey is initiating a program to deploy TrueBeam(TM) technology from Varian Medical Systems (NYSE:VAR) across its network of cancer treatment clinics.
(0)
(0)Varian Medical Systems (VAR) Stock Research Links
Scroll down for more posts ▼